These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9058760)

  • 1. Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury.
    Kossmann T; Stahel PF; Morganti-Kossmann MC; Jones JL; Barnum SR
    J Neuroimmunol; 1997 Mar; 73(1-2):63-9. PubMed ID: 9058760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury.
    Stahel PF; Morganti-Kossmann MC; Perez D; Redaelli C; Gloor B; Trentz O; Kossmann T
    J Neurotrauma; 2001 Aug; 18(8):773-81. PubMed ID: 11526983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis.
    Stahel PF; Frei K; Fontana A; Eugster HP; Ault BH; Barnum SR
    Am J Pathol; 1997 Oct; 151(4):897-904. PubMed ID: 9327721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.
    Jongen PJ; Doesburg WH; Ibrahim-Stappers JL; Lemmens WA; Hommes OR; Lamers KJ
    Acta Neurol Scand; 2000 Feb; 101(2):116-21. PubMed ID: 10685859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse CNS involvement in systemic lupus erythematosus: intrathecal synthesis of the 4th component of complement.
    Jongen PJ; Boerbooms AM; Lamers KJ; Raes BC; Vierwinden G
    Neurology; 1990 Oct; 40(10):1593-6. PubMed ID: 2215952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
    Asano T; Ito H; Kariya Y; Hoshi K; Yoshihara A; Ugawa Y; Sekine H; Hirohata S; Yamaguchi Y; Sato S; Kobayashi H; Migita K; Ohira H; Hashimoto Y; Watanabe H
    PLoS One; 2017; 12(10):e0186414. PubMed ID: 29036223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of the complement factors C3 and C4 within the central nervous system over the course of aseptic meningitis.
    Frydén A; Forsberg P; Link H
    Acta Neurol Scand; 1983 Sep; 68(3):157-63. PubMed ID: 6650127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased interleukin-12 levels in human cerebrospinal fluid following severe head trauma.
    Stahel PF; Kossmann T; Joller H; Trentz O; Morganti-Kossmann MC
    Neurosci Lett; 1998 Jun; 249(2-3):123-6. PubMed ID: 9682832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Annunziata P; Volpi N
    Acta Neurol Scand; 1985 Jul; 72(1):61-4. PubMed ID: 4050318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.
    Csuka E; Morganti-Kossmann MC; Lenzlinger PM; Joller H; Trentz O; Kossmann T
    J Neuroimmunol; 1999 Nov; 101(2):211-21. PubMed ID: 10580806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-resolved immunofluorometric assay of complement C3: application to cerebrospinal fluid.
    Gaillard O; Meillet D; Diemert MC; Musset L; Delattre J; Schuller E; Galli J
    Clin Chem; 1993 Feb; 39(2):309-12. PubMed ID: 8432021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function.
    Morganti-Kossmann MC; Hans VH; Lenzlinger PM; Dubs R; Ludwig E; Trentz O; Kossmann T
    J Neurotrauma; 1999 Jul; 16(7):617-28. PubMed ID: 10447073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The determination of the complement components C1q, C4 and C3 in serum and cerebrospinal fluid by radioimmunoassay.
    Dujardin BC; Driedijk PC; Roijers AF; Out TA
    J Immunol Methods; 1985 Jun; 80(2):227-37. PubMed ID: 3925023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2016 Dec; 22(6):823-830. PubMed ID: 27273074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.
    Lenzlinger PM; Marx A; Trentz O; Kossmann T; Morganti-Kossmann MC
    J Neuroimmunol; 2002 Jan; 122(1-2):167-74. PubMed ID: 11777556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
    Maier B; Lehnert M; Laurer HL; Mautes AE; Steudel WI; Marzi I
    Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.
    Aeinehband S; Lindblom RP; Al Nimer F; Vijayaraghavan S; Sandholm K; Khademi M; Olsson T; Nilsson B; Ekdahl KN; Darreh-Shori T; Piehl F
    PLoS One; 2015; 10(4):e0122048. PubMed ID: 25835709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation in Lyme neuroborreliosis--increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS.
    Henningsson AJ; Ernerudh J; Sandholm K; Carlsson SA; Granlund H; Jansson C; Nyman D; Forsberg P; Nilsson Ekdahl K
    J Neuroimmunol; 2007 Feb; 183(1-2):200-7. PubMed ID: 17157926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid complement proteins in neurological disease.
    Price P; Cuzner ML
    J Neurol Sci; 1980 Apr; 46(1):49-54. PubMed ID: 6966324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.